Transaction · 0002014386-26-000006

Murray Jason Hulse

Murray Jason Hulse, CF, CEO, CHAIR, reported an open-market or private sale at PACS Group, Inc. involving 74844.000000 shares for an estimated $3313373.82. Reported holdings after the transaction were 54996930.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCF, CEO, CHAIR
PACSPACS Group, Inc.
Filing timeAug 20
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$43.58
Pre-filing
1mo ago +5.9%1w ago +11.2%1d ago +2.0%
Returns since
7d +1.5%30d -3.3%90d -3.3%180d -3.3%1y -3.3%

PACS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PACS since 2026-08-20Filed 15 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002014386-26-000006
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 20, 2026, 12:32 AM · 3d delay
Shares
74.8k sh
$4.42k per share
Estimated value
-$331M
Computed from shares × price
Holdings after
54.9M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Co-Founder, CEO & Chairman

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.805 to $43.8025 per share of common stock. The Reporting Person…

  3. F3

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.51 per share of common stock. The Reporting Person un…

  4. F4

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.67 per share of common stock. The Reporting Person un…

  5. F5

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.84 to $44.80 per share of common stock. The Reporting Person un…

  6. F6

    The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.845 to $44.86 per share of common stock. The Reporting Person u…

Original filing · 0002014386-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PACS